Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool (PharmTool)
Opioid Abuse, Prescription Opioid Abuse
About this trial
This is an interventional prevention trial for Opioid Abuse
Eligibility Criteria
Inclusion Criteria: A large chain retail pharmacy chain in the Cincinnati or Columbus, Ohio area Exclusion Criteria: None This study does not involve individual patients as randomization will occur among pharmacies.
Sites / Locations
- University of Cincinnati
- University of Utah
Arms of the Study
Arm 1
Arm 2
Experimental
Other
Intervention Pharmacy Site
Control Pharmacy Site
Pharmacies randomized to the experimental arm will be exposed to the intervention condition. Patients at the intervention pharmacy identified as at elevated risk will receive confirmatory screening for opioid risk. Those with confirmed moderate risk will receive a brief motivational intervention for medication misuse and an offer of naloxone dispensation. Those with high risk will receive a brief motivational intervention leading to warm handoff treatment linkage intervention to primary or specialty substance use care with an offer for naloxone dispensation.
Standard of Care is the treatment as usual condition, which follows federal and Ohio state pharmacy requirements for pharmacists where in patients filling prescriptions receive information and opt-in counseling. Ohio State law requires pharmacist to not dispense an opioid supply >90 days, with a specific prohibition on dispensations ≥14 days after prescriptions are issued. Pharmacists are also required to perform a universal prescription drug medication review before initial dispensation and offer brief counseling (e.g., unstandardized information about medication safety) for new/modified prescription therapies.